Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 6.11 Delayed Data As of Mar 31 |  -0.045 / -0.73%Today’s Change | 5.39 Today|||52-Week Range 18.73 | -4.46% Year-to-Date |
Latest IOVA News | Press Releases
| Why Is Iovance Biotherapeutics (IOVA) Down 9.2% Since Last Earnings Report? Mar 30 / Zacks.com - Paid Partner Content | Iovance (IOVA) Completes Rolling BLA Filing for Melanoma Drug Mar 27 / Zacks.com - Paid Partner Content |
| Why Shares of Iovance Biotherapeutics Jumped Monday Mar 27 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.15 |
| Today’s open | 6.14 |
| Day’s range | 6.04 - 6.25 |
| Volume | 184,844 |
| Average volume (3 months) | 4,632,663 |
| Market cap | $1.5B |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | -11.42% |
| Earnings growth (this year) | +1.78% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RCKTRocket Pharmaceutica... | +0.91 | +5.59% |
| ---- | ||
| RCUSArcus Biosciences In... | +0.77 | +4.41% |
| ARVNArvinas Inc | +0.47 | +1.75% |
Data as of 4:00pm ET, 03/31/2023
Financials
| Next reporting date | May 9, 2023 |
| EPS forecast (this quarter) | -$0.57 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$395.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |
Forecasts
